2007
DOI: 10.1038/emm.2007.67
|View full text |Cite
|
Sign up to set email alerts
|

Effect of bosentan on the production of proinflammatory cytokines in a rat model of emphysema

Abstract: Endothelin (ET) receptor antagonists have been developed to produce a reduction of ET related effects in various diseases, as well as in animal models of airway inflammation. We aimed to investigate the anti-inflammatory potential of bosentan on a rat model of emphysema. Thirty Wistar male rats were classified as control group (group 1), intratracheally (i.t.) instilled with saline, treated with vehicle solution; elastase group (group 2), i.t. instilled with porcine pancreatic elastase (PPE), treated with vehi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(3 citation statements)
references
References 24 publications
1
2
0
Order By: Relevance
“…A previous study demonstrated that bosentan treatment significantly reduced the production of reactive oxygen species by PMN during acute lung inflammation [29]. Another study demonstrated diminished levels of the pro-inflammatory cytokines TNFα, interleukin-1, interleukin-6 and interleukin-8 in rat pulmonary tissue following bosentan treatment of induced emphysema [30]. Both doses of bosentan used in the current study demonstrated pronounced reduction of lung injury.…”
Section: Discussionsupporting
confidence: 49%
“…A previous study demonstrated that bosentan treatment significantly reduced the production of reactive oxygen species by PMN during acute lung inflammation [29]. Another study demonstrated diminished levels of the pro-inflammatory cytokines TNFα, interleukin-1, interleukin-6 and interleukin-8 in rat pulmonary tissue following bosentan treatment of induced emphysema [30]. Both doses of bosentan used in the current study demonstrated pronounced reduction of lung injury.…”
Section: Discussionsupporting
confidence: 49%
“…Experimental evidence suggests that this indeed, might be the case. For example, Gamze et al [128] reported that the ET A /ET B blocker bosentan significantly reduced the concentration of pro-inflammatory cytokines in a rat model of emphysema. More recently, Trabold et al [129] reported that bosentan reduced the oxidative burst in the lung in an acid-aspiration rat model.…”
Section: Endothelin and Pneumoniamentioning
confidence: 99%
“…Inflammation also plays a crucial role in the initiation and progression of hyperlipidemia. It is regulated by proinflammatory mediators and cytokines, including IL-1 β , IL-6, IL-18, and TNF- α [ 50 ]. In our study, D. odorifera leaf extract had an anti-inflammatory effect in hyperlipidemic rats.…”
Section: Discussionmentioning
confidence: 99%